Hepagene Therapeutics
Shanghai, China· Est.
Hepagene Therapeutics develops novel therapies for liver diseases, including hepatitis B and non-alcoholic steatohepatitis (NASH).
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Hepagene Therapeutics develops novel therapies for liver diseases, including hepatitis B and non-alcoholic steatohepatitis (NASH).
Infectious DiseaseMetabolic